Healthcare · Industry
Biotechnology - List & Prices (656 stocks)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Seer, Inc. | SEER | $1.95 | $107.98M | — | |
| RenovoRx, Inc. | RNXT | $2.39 | $107.86M | — | |
| Oncolytics Biotech Inc. | ONCY | $0.84 | $107.52M | — | |
| Anixa Biosciences, Inc. | ANIX | $3.07 | $104.45M | — | |
| Coeptis Therapeutics Holdings Inc | COEP | $16.40 Apr 24, 2026 | $102.06M | — | |
| Polaryx Therapeutics, Inc. | PLYX | $2.00 | $99.69M | — | |
| Atara Biotherapeutics, Inc. | ATRA | $9.76 | $97.97M | — | |
| Cognition Therapeutics, Inc. | CGTX | $1.03 | $97.95M | — | |
| Pelthos Therapeutics Inc. | PTHS | $24.35 | $93.22M | — | |
| Kalaris Therapeutics, Inc. | KLRS | $3.90 | $92.84M | — | |
| Acrivon Therapeutics, Inc. | ACRV | $2.13 | $91.28M | — | |
| Verrica Pharmaceuticals Inc. | VRCA | $5.30 | $91.05M | — | |
| Fortress Biotech, Inc. | FBIO | $2.72 | $90.71M | 1.0 | — |
| ImmuCell Corporation | ICCC | $9.90 | $89.91M | 141.4 | — |
| Rallybio Corporation | RLYB | $16.93 | $89.88M | 2.1 | — |
| Adicet Bio, Inc. | ACET | $9.59 | $89.78M | — | |
| Aldeyra Therapeutics, Inc. | ALDX | $1.48 | $89.28M | — | |
| OS Therapies Incorporated | OSTX | $1.88 | $87.37M | — | |
| Gossamer Bio, Inc. | GOSS | $0.18 | $85.69M | — | |
| Cardiff Oncology, Inc. | CRDF | $1.09 | $84.80M | — | |
| iBio, Inc. | IBIO | $1.31 | $84.24M | — | |
| Alterity Therapeutics Limited | ATHE | $4.54 | $82.67M | — | |
| OKYO Pharma Limited | OKYO | $1.57 | $82.39M | — | |
| Yarrow Bioscience Inc | YARW | $30.21 | $80.65M | — | — |
| MAIA Biotechnology, Inc. | MAIA | $1.32 | $80.30M | — | |
| MediciNova, Inc. | MNOV | $1.63 | $80.23M | — | |
| Telomir Pharmaceuticals, Inc. | TELO | $1.16 | $79.78M | — | |
| Apollomics, Inc. | APLM | $27.50 | $79.63M | — | |
| Sangamo Therapeutics, Inc. | SGMO | $0.19 May 26, 2026 | $78.71M | — | |
| Gain Therapeutics, Inc. | GANX | $1.80 | $78.56M | — | |
| Dogwood Therapeutics, Inc. | DWTX | $2.29 | $77.84M | 1.2 | — |
| Rein Therapeutics Inc. | RNTX | $0.89 | $76.70M | — | |
| NeurAxis, Inc. | NRXS | $5.96 | $74.84M | — | |
| Cingulate Inc. | CING | $5.10 | $74.16M | — | |
| Tenax Therapeutics, Inc. | TENX | $1.94 | $72.60M | — | |
| Nutriband Inc. | NTRB | $5.97 | $72.57M | — | |
| Champions Oncology, Inc. | CSBR | $5.22 | $72.52M | — | |
| Pliant Therapeutics, Inc. | PLRX | $1.16 | $71.83M | — | |
| LeonaBio, Inc. | LONA | $7.56 | $71.23M | — | |
| Spero Therapeutics, Inc. Common Stock | SPRO | $1.21 | $70.46M | 8.6 | — |
| Lixte Biotechnology Holdings, Inc. | LIXT | $3.71 Sep 2, 2026 | $69.96M | — | |
| Serina Therapeutics, Inc. | SER | $2.73 | $69.34M | — | |
| PMV Pharmaceuticals, Inc. | PMVP | $1.29 | $68.96M | — | |
| ETHZilla Corporation | ETHZ | $5.85 May 1, 2026 | $68.63M | — | |
| INmune Bio Inc. | INMB | $2.44 | $67.72M | — | |
| XBiotech Inc. | XBIT | $2.20 | $67.07M | — | |
| BioStem Technologies, Inc. | BSEM | $3.71 | $66.15M | 4.1 | — |
| Heron Therapeutics, Inc. | HRTX | $0.34 | $65.29M | — | |
| Boundless Bio, Inc. | BOLD | $2.87 | $65.29M | — | |
| eXoZymes, Inc. | EXOZ | $6.85 | $63.58M | — |
Seer, Inc.
Healthcare / Biotechnology
- Market Cap
- $107.98M
- P/E
- unprofitable
RenovoRx, Inc.
Healthcare / Biotechnology
- Market Cap
- $107.86M
- P/E
- unprofitable
Oncolytics Biotech Inc.
Healthcare / Biotechnology
- Market Cap
- $107.52M
- P/E
- unprofitable
Anixa Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $104.45M
- P/E
- unprofitable
Coeptis Therapeutics Holdings Inc
Healthcare / Biotechnology
- Market Cap
- $102.06M
- P/E
- unprofitable
Polaryx Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $99.69M
- P/E
- unprofitable
Atara Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $97.97M
- P/E
- unprofitable
Cognition Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $97.95M
- P/E
- unprofitable
Pelthos Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $93.22M
- P/E
- unprofitable
Kalaris Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $92.84M
- P/E
- unprofitable
Acrivon Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $91.28M
- P/E
- unprofitable
Verrica Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $91.05M
- P/E
- unprofitable
Fortress Biotech, Inc.
Healthcare / Biotechnology
- Market Cap
- $90.71M
- P/E
- 1.0
ImmuCell Corporation
Healthcare / Biotechnology
- Market Cap
- $89.91M
- P/E
- 141.4
Rallybio Corporation
Healthcare / Biotechnology
- Market Cap
- $89.88M
- P/E
- 2.1
Adicet Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $89.78M
- P/E
- unprofitable
Aldeyra Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $89.28M
- P/E
- unprofitable
OS Therapies Incorporated
Healthcare / Biotechnology
- Market Cap
- $87.37M
- P/E
- unprofitable
Gossamer Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $85.69M
- P/E
- unprofitable
Cardiff Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $84.80M
- P/E
- unprofitable
iBio, Inc.
Healthcare / Biotechnology
- Market Cap
- $84.24M
- P/E
- unprofitable
Alterity Therapeutics Limited
Healthcare / Biotechnology
- Market Cap
- $82.67M
- P/E
- unprofitable
OKYO Pharma Limited
Healthcare / Biotechnology
- Market Cap
- $82.39M
- P/E
- unprofitable
Yarrow Bioscience Inc
Healthcare / Biotechnology
- Market Cap
- $80.65M
MAIA Biotechnology, Inc.
Healthcare / Biotechnology
- Market Cap
- $80.30M
- P/E
- unprofitable
MediciNova, Inc.
Healthcare / Biotechnology
- Market Cap
- $80.23M
- P/E
- unprofitable
Telomir Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $79.78M
- P/E
- unprofitable
Apollomics, Inc.
Healthcare / Biotechnology
- Market Cap
- $79.63M
- P/E
- unprofitable
Sangamo Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $78.71M
- P/E
- unprofitable
Gain Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $78.56M
- P/E
- unprofitable
Dogwood Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $77.84M
- P/E
- 1.2
Rein Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $76.70M
- P/E
- unprofitable
NeurAxis, Inc.
Healthcare / Biotechnology
- Market Cap
- $74.84M
- P/E
- unprofitable
Cingulate Inc.
Healthcare / Biotechnology
- Market Cap
- $74.16M
- P/E
- unprofitable
Tenax Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $72.60M
- P/E
- unprofitable
Nutriband Inc.
Healthcare / Biotechnology
- Market Cap
- $72.57M
- P/E
- unprofitable
Champions Oncology, Inc.
Healthcare / Biotechnology
- Market Cap
- $72.52M
- P/E
- unprofitable
Pliant Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $71.83M
- P/E
- unprofitable
LeonaBio, Inc.
Healthcare / Biotechnology
- Market Cap
- $71.23M
- P/E
- unprofitable
Spero Therapeutics, Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $70.46M
- P/E
- 8.6
Lixte Biotechnology Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $69.96M
- P/E
- unprofitable
Serina Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $69.34M
- P/E
- unprofitable
PMV Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $68.96M
- P/E
- unprofitable
ETHZilla Corporation
Healthcare / Biotechnology
- Market Cap
- $68.63M
- P/E
- unprofitable
INmune Bio Inc.
Healthcare / Biotechnology
- Market Cap
- $67.72M
- P/E
- unprofitable
XBiotech Inc.
Healthcare / Biotechnology
- Market Cap
- $67.07M
- P/E
- unprofitable
BioStem Technologies, Inc.
Healthcare / Biotechnology
- Market Cap
- $66.15M
- P/E
- 4.1
Heron Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $65.29M
- P/E
- unprofitable
Boundless Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $65.29M
- P/E
- unprofitable
eXoZymes, Inc.
Healthcare / Biotechnology
- Market Cap
- $63.58M
- P/E
- unprofitable
Showing 401–450 of 656 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.